Myopericarditis in a Male Adolescent Following the Second Shot of COVID-19 Pfizer m-RNA Vaccine: Typical Example and Analysis of 110 Single Case Reports

One of the most powerful weapons against COVID-19 is vaccines. After the worldwide spread of the disease, m-RNA vaccines were authorized not only in adult patients, but also in children and adolescents aged 12–18. Since then, alarming reports of cases of myocarditis and/or pericarditis have been not...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Pediatric Reports
المؤلفون الرئيسيون: Alessandra Piras, Giada Melis, Lucia Cugusi, Pier Paolo Bassareo
التنسيق: مقال
اللغة:الإنجليزية
منشور في: MDPI AG 2022-09-01
الموضوعات:
m-RNA vaccine
COVID-19
myocarditis
pericarditis
adverse event
الوصول للمادة أونلاين:https://www.mdpi.com/2036-7503/14/4/48

الانترنت

https://www.mdpi.com/2036-7503/14/4/48

مواد مشابهة